These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

758 related items for PubMed ID: 21644030

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Current developments with peptide-based human tumor vaccines.
    Khazaie K, Bonertz A, Beckhove P.
    Curr Opin Oncol; 2009 Nov; 21(6):524-30. PubMed ID: 19770763
    [Abstract] [Full Text] [Related]

  • 3. A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive setting.
    Gray A, Raff AB, Chiriva-Internati M, Chen SY, Kast WM.
    Immunol Rev; 2008 Apr; 222():316-27. PubMed ID: 18364011
    [Abstract] [Full Text] [Related]

  • 4. T-cell epitope peptide vaccines.
    Elsawa SF, Rodeberg DA, Celis E.
    Expert Rev Vaccines; 2004 Oct; 3(5):563-75. PubMed ID: 15485336
    [Abstract] [Full Text] [Related]

  • 5. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
    Ruffini PA, Neelapu SS, Kwak LW, Biragyn A.
    Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812
    [Abstract] [Full Text] [Related]

  • 6. Molecularly defined vaccines for cancer immunotherapy, and protective T cell immunity.
    Speiser DE, Romero P.
    Semin Immunol; 2010 Jun; 22(3):144-54. PubMed ID: 20413326
    [Abstract] [Full Text] [Related]

  • 7. Tumor-specific antigens and immunologic adjuvants in cancer immunotherapy.
    Seremet T, Brasseur F, Coulie PG.
    Cancer J; 2011 Jun; 17(5):325-30. PubMed ID: 21952282
    [Abstract] [Full Text] [Related]

  • 8. Cancer vaccines: an update with special focus on ganglioside antigens.
    Bitton RJ, Guthmann MD, Gabri MR, Carnero AJ, Alonso DF, Fainboim L, Gomez DE.
    Oncol Rep; 2002 Jun; 9(2):267-76. PubMed ID: 11836591
    [Abstract] [Full Text] [Related]

  • 9. Antitumor vaccination: where we stand.
    Bocchia M, Bronte V, Colombo MP, De Vincentiis A, Di Nicola M, Forni G, Lanata L, Lemoli RM, Massaia M, Rondelli D, Zanon P, Tura S.
    Haematologica; 2000 Nov; 85(11):1172-206. PubMed ID: 11074658
    [Abstract] [Full Text] [Related]

  • 10. [Antitumor immunity and cellular cancer therapies].
    Catros-Quemener V, Bouet F, Genetet N.
    Med Sci (Paris); 2003 Jan; 19(1):43-53. PubMed ID: 12836191
    [Abstract] [Full Text] [Related]

  • 11. [Anti-HER2 vaccines: The HER2 immunotargeting future?].
    Ladjemi MZ, Jacot W, Pèlegrin A, Navarro-Teulon I.
    Pathol Biol (Paris); 2011 Jun; 59(3):173-82. PubMed ID: 19481373
    [Abstract] [Full Text] [Related]

  • 12. Cancer vaccines: between the idea and the reality.
    Finn OJ.
    Nat Rev Immunol; 2003 Aug; 3(8):630-41. PubMed ID: 12974478
    [Abstract] [Full Text] [Related]

  • 13. Dendritic cells for specific cancer immunotherapy.
    Meidenbauer N, Andreesen R, Mackensen A.
    Biol Chem; 2001 Apr; 382(4):507-20. PubMed ID: 11405216
    [Abstract] [Full Text] [Related]

  • 14. Prospects and limitations of recombinant poxviruses for prostate cancer immunotherapy.
    Hwang C, Sanda MG.
    Curr Opin Mol Ther; 1999 Aug; 1(4):471-9. PubMed ID: 11713762
    [Abstract] [Full Text] [Related]

  • 15. Cancer vaccines: a critical review on clinical impact.
    Bitton RJ.
    Curr Opin Mol Ther; 2004 Feb; 6(1):17-26. PubMed ID: 15011777
    [Abstract] [Full Text] [Related]

  • 16. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B, Siegel SE, Kaiser HE.
    Anticancer Res; 1996 Feb; 16(2):661-74. PubMed ID: 8687112
    [Abstract] [Full Text] [Related]

  • 17. Tumor vaccine: current trends in antigen specific immunotherapy.
    Baral R.
    Indian J Exp Biol; 2005 May; 43(5):389-406. PubMed ID: 15900903
    [Abstract] [Full Text] [Related]

  • 18. Combination strategies for enhancing the efficacy of immunotherapy in cancer patients.
    Moschella F, Proietti E, Capone I, Belardelli F.
    Ann N Y Acad Sci; 2010 Apr; 1194():169-78. PubMed ID: 20536466
    [Abstract] [Full Text] [Related]

  • 19. Therapeutic cancer vaccines.
    Acres B, Paul S, Haegel-Kronenberger H, Calmels B, Squiban P.
    Curr Opin Mol Ther; 2004 Feb; 6(1):40-7. PubMed ID: 15011780
    [Abstract] [Full Text] [Related]

  • 20. Cancer therapy and vaccination.
    Aly HA.
    J Immunol Methods; 2012 Aug 31; 382(1-2):1-23. PubMed ID: 22658969
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.